Skip to main content
. 2018 Oct 22;6:111. doi: 10.1186/s40425-018-0424-9

Fig. 2.

Fig. 2

a Best change and b change over time from baseline in sum of target lesion diameters in evaluable patients (n = 48). In a bars for individual patients are color-coded according to tumor PD-L1 status based on a 5% PD-L1 expression cutoff in tumor cells. In b lines for individual patients are color-coded based on confirmed best overall response